Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2009

01-04-2009 | Original Article

Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene

Authors: Toshirou Nishida, Tsuyoshi Takahashi, Akiko Nishitani, Toshihiko Doi, Kuniaki Shirao, Yoshito Komatsu, Kiyokazu Nakajima, Seiichi Hirota, Japanese Study Group on GIST

Published in: International Journal of Clinical Oncology | Issue 2/2009

Login to get access
Metadata
Title
Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene
Authors
Toshirou Nishida
Tsuyoshi Takahashi
Akiko Nishitani
Toshihiko Doi
Kuniaki Shirao
Yoshito Komatsu
Kiyokazu Nakajima
Seiichi Hirota
Japanese Study Group on GIST
Publication date
01-04-2009
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2009
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-008-0822-y

Other articles of this Issue 2/2009

International Journal of Clinical Oncology 2/2009 Go to the issue

Review Article

Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer

Case Report

Primary osteosarcoma of ovary

Case Report

Adenoendocrine cell carcinoma of the gallbladder clinically mimicking squamous cell carcinoma

Case Report

An atypical extrahepatic metastasis of the distal phalanx from hepatocellular carcinoma

Review Article

Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis

Original Article

Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits